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Introduction
Septicemia is a severe pathologic condition that arises when a source of infection

becomes systemic – finding its way to multiple organ systems via the blood. It is clinically
defined by the presence of two or more systemic inflammatory response syndrome (SIRS)
criteria accompanied by suspected infection or infection (Francis, Rich, Williamson, & Peterson,
2010). Patients presenting with sepsis or septic shock progress rather quickly to serious states,
and if left untreated, may rapidly progress to death. Even with treatment, it is estimated mortality
rates for patients with severe sepsis are between 30% and 50% (Stoneking, Denninghoff, Deluca,
Keim, & Munger, 2011). The severity of this condition makes it apparent that it is a major
disease process facing our healthcare system. Over 750,000 new cases of sepsis and septic shock
present each year in the United States accounting for 215,000 deaths annually or 9.3% of all
deaths in the United States yearly (Stoneking et al., 2011).
Given the above facts, it is surprising to learn that septic shock has been recognized
since the earliest days of modern medicine (Puskarish, 2012). Only in recent times, however, has
the importance of early recognition and treatment of sepsis emerged. In 2001, a landmark study
in the treatment of sepsis was released in which researchers were able to reduce the mortality rate
due to sepsis by 16% using a form of bundled care called early goal directed therapy (EGDT)
created by researchers Rivers et. al. (Vorwerk & Coats, 2011). Patient care bundles consist of “a
set of interventions or processes of care distilled from evidence-based practice guidelines that
when implemented as a group, provide a more robust picture of the quality of care provided”
(Thomas, 2007, p. 1211). Thus, bundled care sets are based upon scientifically sound
interventions, with a cohesive shared focus, and directly relatable to metrics of quality of care.
The key to bundled care sets that differentiate them from typical care guidelines and protocols
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lies in their comprehensive nature. Their purposive effects are gathered not only from each
individual intervention, but the additive and interactive effects of using interventions en masse
(Puskarich, 2012). In the case of sepsis, this care bundle took the form of Rivers’s EGDT, which
emphasized early recognition and treatment of sepsis. In fact, Rivers’s EGDT was so successful
that the EGDT concept was adopted by the Surviving Sepsis Campaign (SSC), an international
cooperation of the world’s leading organizations dealing with sepsis. The aim of the SSC is to
improve the diagnosis, management, and survival of patients with sepsis. In 2004, they released
guidelines for hospitals to base their care bundles upon, with the express goal of decreasing
sepsis mortality by 25% by the year 2009 (Francis et al., 2010).
Since the SSC’s formation, several studies have shown markedly improved outcomes
with the use of emergency department (ED) based sepsis protocols. Using EGDT guidelines has
allowed clear identification and quick treatment of sepsis to improve patient outcomes and
mortality rates (Casserly et al., 2011; Francis et al., 2010; Larsen, Mecham, Greenberg, 2011;
Patel, Roderman, Gehrig, Saad, & Bartek, 2010; Puskarish et al., 2011; Sweet et al., 2010;
Uusitalo-Seppal et al., 2011).
Despite the evidence of the effectiveness of EGDT in reducing morbidity and mortality, a
survey given to physicians at 30 academic tertiary care EDs, revealed only 7% of clinicians used
EGDT (Stoneking et al., 2011). Additionally only one study conducted by Casserly and
coworkers (2011) has been published in which EGDT care bundle was incorporated into the care
of septic patients in the intensive care unit (ICU). Casserly’s study created a collaborative
approach in which most critically ill patients with sepsis were transferred from the ED to the ICU
as quickly as possible to receive intensive EGDT bundled care as soon as possible. Their data
suggests “the use of a collaborative protocol for sepsis intervention may decrease the time to
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initiation of resuscitation for patients admitted to the ED with severe sepsis and decrease the time
to transfer to the ICU.” (Casserly et al., 2011)
Another very important and pertinent factor affecting all health care is cost. Many
healthcare facilities are resistant to changes in care that increase cost when the trend nationally is
to reduce costs as much as possible. A study by Jones et al (2011) found that the use of an EGDT
increases direct hospital cost by $7028 per patient. But after performing a net monetary benefit
analysis the researchers found with a 98% probability that EGDT was cost effective (Jones,
2011). This suggests that while initial costs of EGDT implementation are higher, the long term
and overall benefits actually outweigh that cost in value.
An ad hoc committee of specialists at the study hospital developed the Sepsis Powerplan
that was implemented. Dr. Buddy Newton, Medical Director of Antimicrobial Stewardship, laid
the foundation for the plan based upon his vast experience and knowledge of the revisions to the
SSC guidelines. This foundation was expanded upon and turned into an all inclusive multiple
step plan of action by the committee consisting of Dr. David Ratcliff – Chief Medical Officer of
the hospital, Dr. Kyle Hardy – Medical Director of ICU, Terri Church – nurse informaticist,
Rebecca Cowie – critical care CNS, Sheryl Davis – Critical Care Director and CNS, and Teri
Hayden – ED director (personal communication, 2013).
Specific Aims
The purpose of this prospective pre and post design study was to corroborate the
effectiveness of EGDT care bundles as the standard of treatment in an urban hospital by
evaluating the care of patients presenting to the ED with septic shock and to gather further data
relating to collaboration between the ED and ICU in EGDT care bundles dealing with septic
patients. Primary variables of interest included time to: fluid administration, vasopressor
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administration, catheter insertion, initial antibiotics, and transfer to ICU - along with mortality
rates and length of hospital stay. These data combined with that relating to compliance help to
answer the question: Can sepsis EGDT be implemented in an urban hospital, with no prior
experience in using a treatment protocol for septic patients, to benefit those patients? The
primary focus of this research, then, is to determine if there is a difference between the pre and
post implementation populations in the key variables of interest.
Methods
Approval was received from the hospital’s quality improvement board and the University
of Arkansas’s institutional review boards (IRB) before the commencement of this study.
Sample	
  	
  
This	
  study	
  used	
  non-‐random	
  selection	
  to	
  divide	
  its	
  subjects	
  into	
  two	
  groups:	
  that	
  of	
  
pre-‐implementation	
  and	
  that	
  of	
  post	
  implementation.	
  The	
  post-‐implementation	
  sample	
  for	
  
this	
  study	
  consisted	
  of	
  all	
  patients	
  admitted	
  to	
  the	
  ED	
  between	
  May	
  2013	
  and	
  October	
  2013	
  
with	
  an	
  admitting	
  diagnosis	
  of	
  sepsis/septic	
  shock	
  and	
  who	
  were	
  administered	
  the	
  Sepsis	
  
Powerplan	
  care	
  bundle.	
  	
  Information	
  was	
  compared	
  to	
  corresponding	
  patient	
  data	
  for	
  the	
  
same	
  6	
  month	
  frame	
  of	
  the	
  preceding	
  year	
  (2012)	
  prior	
  to	
  implementation	
  of	
  the	
  full	
  care	
  
bundle	
  as	
  the	
  pre-‐implementation	
  group.	
  In	
  the	
  context	
  of	
  this	
  study,	
  a	
  diagnosis	
  of	
  sepsis	
  
in	
  a	
  patient	
  was	
  established	
  with	
  the	
  presence	
  of	
  two	
  or	
  more	
  of	
  the	
  following	
  SIRS	
  
indicators:
•

Temperature <96.8 F or >100.4 F

•

Respiratory Rate >20

•

Heart rate >90

•

White Blood Count <4000 or >12000 OR >10% bands

	
  

6	
  
•

Systolic blood pressure <90, Glucose >150 in absence of Diabetes Mellitus

•

Urine output < 35 cc/ hr (non hemodialysis patient)

•

Altered mental status (acute), O2 saturation <92% on room air, or Lactate >4.0]

•

A known or suspected infection (determined by treating physician)

For the purpose of this study, sepsis organ dysfunction was determined on a case by case basis
by the physician in charge of the case based upon data obtained through lab tests as indicated by
the Sepsis Powerplan.
Design
This study was constructed as a retrospective review prior to the implementation of the
Sepsis Powerplan and a prospective review post implementation. Data from the 6 month period
of patients with sepsis in 2012 served as the control and the data from the corresponding 6
months in 2013 served as the test group.
Variables
This study analyzed the following among both control and test groups:
•

Time from admission to first fluid administration in minutes

•

Time from admission to first vasopressor administration in minutes

•

Time from admission to central venous arterial pressure (CVAP) catheter insertion in
minutes

•

Time from admission to initial antibiotics administration in minutes
-

Specific antibiotic administered

-

Whether a culture and sensitivity was drawn before antibiotic administered

•

Time from admission to transfer to ICU (if necessary) in minutes

•

Mortality Rates
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•

Length of hospital stay in days

•

Compliance with bundle among providers as measured through documentation of all
portions of Sepsis Powerplan administered

Procedure
The Sepsis Powerplan was administered to all patients presenting to the ED at the study
hospital who met the definition of sepsis. For these patients, admission to the ICU was
considered at the discretion of the physician in charge. Patients with severe sepsis, consisting of
the presence of two SIRS indicators plus one or more indicators of ‘sepsis-related’ organ
dysfunction were admitted to the ICU. All patients in septic shock –presenting with the two
sepsis indicators and hypotension unresponsive to appropriate fluid resuscitation were admitted
to the ICU. All patients were administered the care bundle and all data in the variables listed
came from the study hospital’s medical records.
Data Analysis
To ensure the privacy of patients and staff, all data was de-identified according to HIPPA
guidelines for research. Each patient record was assigned a four digit alphanumeric code. The
first digit was either an S, indicating the patient is in the pre-implementation population, or an I,
indicating the patient is in the post implementation population, while the second digit will
indicate which floor [1-5] the patient was on in the hospital. The final two digits were a unique,
randomized two digit patient identifier number [00 – 99]. Data was collected for a 6 month span
from May 2013 – October 2013 for the post implementation. Corresponding data from the same
6 month frame of the preceding (2012) year were examined as the pre implementation data.
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Results
The control group inclusionary criteria netted 39 patients, while the test group yielded 31

patients. Results were analyzed in a between-groups design, using two tailed t tests, z tests of
proportions, and a Kruskal-Wallis one way ANOVA – all with an alpha level of 0.05 and the null
hypothesis in all cases being that there was no difference between the test group and the control
group. Two tailed t tests of time to fluid administration, t = 1.504, p = 0.137 with df = 68; time to
vasopressor administration, t = 0.355, p = 0.729 with df = 11; time to antibiotic administration, t
= 1.476, p = 0.145 with df = 68; time to ICU transfer, t = 0.555, p = 0.587 with df = 16; and
length of hospital stay, t = 0.545, p = 0.587 with df = 68; failed to reveal a significant difference
in the means between groups. Figures 1 and 2 show the similarity in means for these variables. A
t test on time to central venous/arterial pressure (CVAP) catheter insertion was impossible due to
insufficient data. Z tests of proportions on antibiotic culture and sensitivity obtainment, z = 1.836, p = 0.0658; and on mortality, z = 1.836, p = 0.0658 failed to reveal a significant effect.
Figure 3 graphs the proportions for these variables. A Kruskal-Wallis one way ANOVA for
categorical data revealed a significant effect for group on mortality, chi-squared = 114.24, p =
0.0000 with df = 1, indicating that variance in mortality can be accounted for by variance in the
group. Therefore, according to t test results and z test results, the null hypothesis fails to be
rejected while, according to the modified one way ANOVA, the null hypothesis is rejected.
Figure 1.

-	
  1	
  -	
  Pre	
  versus	
  post	
  comparison	
  of	
  "Length	
  of	
  Hospital	
  Stay"	
  means	
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Figure 2

-	
  3	
  -	
  Pre	
  versus	
  post	
  comparison	
  of	
  means	
  

Figure 3

-	
  4	
  –	
  Pre	
  versus	
  post	
  comparison	
  of	
  frequencies	
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Figure 4

-	
  5	
  -	
  Antibiotic	
  administration	
  frequencies	
  

Figure 5

-	
  6	
  -	
  Pre	
  antibiotic	
  administration	
  frequencies	
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Figure 6

-	
  7	
  -	
  Post	
  antibiotic	
  administration	
  frequencies	
  

Limitations
This study’s primary limitation is that of time. Since the inclusion criteria is anyone
presenting to the ED at the facility of interest with SIRS indicators indicating a diagnosis of
sepsis over certain time frames for both pre and post implementation groups, a longer time of
study is necessary to have a larger sample size. A larger sample size would better reflect the
distribution of key variables amongst both pre and post populations, potentially yielding more
statistically relevant information. Another crucial limitation is that the design of the study was
created using an early draft of the implemented treatment protocol. Thus, data over some
variables of interest to the protocol was not collected while certain data over variables that were
actually collected was done so in a limited fashion, for example being categorical as opposed to
comparatively numerical. This results in a narrowing in the scope of this study as less relevant
information can be presented. The final limitation of the study is that a clear start time of patient
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care was hard to identify given the provided documentation. In order to quantify how long it took
for a given patient to receive fluid or antibiotics, not only is the time of administration required,
so too is a clear time zero. This was not the case, however, as identifying exactly when a patient
presented to the health system proved difficult as this factor was not defined in ED
documentation and because mode of arrival to the ED varied between ambulance, where
sometimes treatment would begin en route, and self transport, where treatment would not begin
until after triage in the ED.
Discussion
Data was collected on all patients who presented to the facility of interest’s ED meeting
SIRS criteria for an initial diagnosis of sepsis. The pre-implementation group consisted of 39
patients who came into the ED between May and October of 2012 while the post-implementation
group was made up of 31 patients who presented during the same months in 2013. Ultimately,
the statistical analysis of data reveals that the only statistically significant difference between the
pre-implementation and post-implementation groups occurs in regards to mortality. This in itself
may demonstrate that the protocol had a significant impact on patient outcome. Yet, there is
more to the data than just the final values of the statistical tests.
Comparison of Means
Figures 1 and 2 provide a clear illustration of the means of several variables of interest.
With the first variable, time to fluid administration, it is interesting to see that, despite being
statistically insignificant, the mean actually increased in the post-implementation group. There is,
however, an outlier in the post-implementation group where fluids were not administered until
much later in treatment (14.7 hours), when the patient was already on the floor. Since the sample
sizes of both the control and test group are so small, it is worth analyzing the data sets with the
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removal of the outlier to see if there was actually an effect on fluid administration time by the
sepsis treatment protocol. Doing so lowers the mean in the test group to 137.93 and a t test
comparing those means and the modified data sets yields t = .983 and p = .329, so the change is
still statistically insignificant. Further study is required to identify what factors would potentially
cause fluid administration time to increase in the test group.
In the second variable of interest, time to vasopressor administration, the mean time
dropped from 981 minutes in the control group to 788 in the test group. But, the sample size for
this variable is even smaller then the overall sample size for both groups because only those who
clinically required vasopressors had them administered. This consisted of 6 patients in the
control group and 7 in the test group. Because these numbers are so small, there is an extremely
high degree of standard error in the means and it is no surprise that the difference in them is not
statistically significant.
The next variable of interest, time to antibiotic administration, has a much lower, though
statistically insignificant, average in the post-implementation group at 214 minutes than in the
pre-implementation group at 368 minutes. As with fluid administration time, there was an outlier
in the post-implementation data set where for an unknown reason antibiotic administration was
delayed. Removal of this outlier lowers the post-implementation average further to 194 minutes.
A t test on the modified data set yields t = 1.663 and p = .101 which is still statistically
insignificant with an alpha level of 0.05. Though it is statistically insignificant it is a good
indicator for the hospital that mean antibiotic administration time dropped so much between
groups. It represents a step in the right direction and further analysis may reveal factors that lead
to decreased antibiotic administration time that can be applied to fluid administration in order to
decrease that time in the future. It is worth noting here that the updated SSC standards propose
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rapid antibiotic administration and hemodynamic support with EGDT be accomplished within
the first three hours of treatment (Dellinger et al., 2013). The hospital of interest falls within that
guideline on fluid administration, but falls just shy of this standard for antibiotic administration.
Further study into how other facilities decrease overall time to antibiotic administration is
necessary to identify such practices and implement them in the facility of interest to further
reduce antibiotic administration time.
With the next variable, time to ICU transfer, the average in the post-implementation
group is about 20 minutes higher at 276 minutes than that of the pre-implementation group at
255 minutes. This difference was shown to be statistically insignificant and with approximately
no difference in the standard error of the means it is safe to say that there is no meaningful
difference between the two groups in that regard. It is interesting to note that the implemented
Sepsis Powerplan is divided into two phases, mirroring the 2012 SSC guidelines of initially
providing fluid resuscitation and antibiotics before moving on to more complex treatments like
vasopressors and other hemodynamic therapies. The SSC’s goals are to have the first phase of
treatment be completed within three hours and the second to occur within six hours (Dellinger et
al., 2013), while the facility of interest’s goal is to do phase one in the ED and complete phase
two in the ICU. In order to accomplish that goal then, further research must be done to identify
and implement ways to decrease time in ED as the current time of approximately five hours to
ICU is simply too long for the treatment protocols.
The final variable with means to compare is the length of hospital stay in days. The mean
for the control group was 8.92 while the test group was 8.26. As this difference is statistically
insignificant and the standard error of the means is approximately equal, it is safe to say that
EGDT had no effect on the length of stay in this hospital. However, according to a CDC study in
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2008 (Hall, Williams, DeFrances, & Golosinskiy, 2011), the average length of stay for those
hospitalized for sepsis is 8.4 days. By this marker, the study hospital is just under the national
average.
Comparison of Proportions and Frequencies
Figure 3 clearly shows that there is a difference between both groups when it comes to
blood culture and sensitivity obtainment and mortality. In the pre-implementation group, 10% of
patients did not have their blood cultures drawn before antibiotic administration while in the post
implementation group, 0% of patients did not have their blood cultures drawn prior to antibiotic
administration. At the same time, 10% of patients died in the pre-implementation group while
0% died in the post-implementation group. With a significance level of 95%, these results prove
statistically insignificant since z tests result in a p value of .0658 for both. Yet, having no deaths
in the post-implementation group is definitely noteworthy. If the significance level is dropped to
just below 93.42%, these values are meaningful and the null hypothesis would be rejected.
Therefore, accepting a 93% confidence level (as opposed to 95%) would have concluded that the
difference in proportions for blood culture obtainment and mortality between groups did not
occur by chance. This alone can’t lead to the conclusion that the EGDT protocol directly caused
these things to happen, but it is reasonable to presume that the protocol plus staff awareness and
all other environmental factors post-implementation are leading to conditions in which blood
cultures are taken more frequently and patients are dying less frequently. Further study is of
course needed to verify this.
In conducting this study, data was collected not only on when antibiotics were
administered but which antibiotics were administered first. Figure 4 shows the percentages with
which different types of antibiotics were given and Figures 5 and 6 show these values as
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percentages of the whole. The treatment protocol calls for a shotgun approach initially, that is
using multiple broad spectrum antibiotics while blood cultures are running, before switching to
more specific drug. According to the protocol, patients should receive the following antibiotics
sequentially before switching to something more bacteria specific: meropenem, vancomycin, and
levofloxacin. Unsurprisingly, most patients in the control group received a variety of antibiotics
other than those three. Of interest is the proportion that actually received meropenem first in the
test group. As can be seen in Figure 4 that is only about 19%, which is curious considering that it
should be 100%. Further analysis as to why this occurred is necessary. Further education over
the protocol may be necessary for those using it.
Analysis of Variance
Because 0% of patients in the post-implementation group died, while 10.2% of patients
died in the pre-implementation group, a Kruskal-Wallis one-way ANOVA for categorical
information was conducted to see if the variation in the group truly accounts for the variation in
mortality. This test gets to the heart of this study as it attempts to say whether being in the pre or
post group had an effect on whether or not a patient died. Since the p-value of this test is so low
that it is essentially zero, the null hypothesis of equal variance per group was rejected at an alpha
level of .0001. Because of this, it can be said with confidence that the variance in the group
accounts for the variance in the mortality. As variance in group can only be pre and post and the
variance in mortality can only be yes or no, then it can be said in this study with certainty that
which group a patient was in does help to explain whether or not they died. While other factors
could account for this and further analysis is necessary to say for sure due to the small number of
subjects, this is a strong indication that EGDT at this hospital has indeed been effective at
reducing mortality.
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Recommendations
The scope of this study is limited to the hospital in which it took place, so

recommendations based on this study’s analysis will be aimed at this target hospital. Since the
major weakness of this study is that the sample sizes are too low, in order for the hospital to
determine whether or not its treatment protocol is having an effect on patient outcomes is to have
continual monitoring with review. This will ultimately determine whether or not the trends seen
by this study continue because eventually, the sample size of the post-implementation patients
will become large enough to determine statistically significant differences on variables of
interest. It is also recommended that the hospital continue to frequently educate its healthcare
professionals on the treatment protocols. This is a new protocol implemented earlier this year,
and given the low percentage of patients who received the appropriate first antibiotic in the test
group, it is assumed that those using the protocol may not be familiar with it. Other more specific
recommendations include: individual chart review for outlier patients to determine why indeed
those patients were outliers, identifying systemically factors that would cause fluid
administration time to increase with protocol implementation, and identification and
implementation of methods to reduce overall antibiotic administration times and time spent in
the ED before ICU transfer.
The Sepsis Powerplan is an important protocol which may prove to increase the
identification and treatment of patients experiencing septicemia. It may have a major impact on
overall mortality rates in these high risk patients. Implementation of such a protocol needs
continuous evaluation for compliance with implementation guidelines to maximize its impact on
patient care.
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